cαstx1
mAbexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2010 (NCT01252199)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Shiga toxinImmunity, passive
Shiga toxin immunity, passive
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- calphastx1
- cαstx1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01252199 | Phase 2 | Nov 1, 2010 | LFB Biotechnologies, SAS, Thallion Pharmaceuticals |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| LFB Biotechnologies, SAS | For profit | 1 | 0 | 1 | 2010 |
| Thallion Pharmaceuticals | For profit | 1 | 1 | 1 | 2010 |
2 organizations
Page 1 / 1